SCHEMBL8701115

SCHEMBL8701115

Cc1cc(C=O)sc1CN1CCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
ALDH1A1 P00352 6/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ERAP1 Q9NZ08 3/20 0.35
MCL1 Q07820 1/20 0.35
ALDH1A3 P47895 2/20 0.35
HRH3 Q9Y5N1 2/20 0.34
POLB P06746 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPK1 P28482 1/20 0.34
GLA P06280 3/20 0.33
GAA P10253 3/20 0.33
HPGD P15428 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11764805 0.74 CYP2A6 (0.39) KMT2AMEN1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL10673019 0.72 CYP1A2 (0.39) KMT2AMEN1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL8697208 0.72 ALDH1A1 (0.38) KMT2AMEN1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL5364149 0.71 CYP2A6 (0.34) ALDH1A1CYP2A6
SCHEMBL8697365 0.67 ADRA1D (0.55) ALDH1A1SMN1; SMN2KDM4EMAPTL3MBTL1
SCHEMBL22342658 0.67 HIF1A (0.38) ALDH1A1KDM4ECYP2A6
SCHEMBL9034157 0.66 HRH3 (0.33) KMT2AMEN1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL7443738 0.66 ALDH1A3 (0.55) KMT2AMEN1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL8697211 0.66 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2KDM4EMAPTL3MBTL1
SCHEMBL2222194 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5834460-A FOR TREATMENT OF BRAIN OR PSYCHOLOGICAL DISORDERS, ALZHEIMER*S DISEASE, MENTAL RETARDATION OR AUTISM YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1998-11-10 US disclosed
EP-0696586-A1 SERINE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1996-02-14 EP disclosed